Temperature Extremes Tied to Higher Rates of Missed Primary Care Appointments
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
THURSDAY, July 25, 2024 -- Temperature extremes are associated with higher rates of missed primary care appointments, according to a study published online June 20 in the American Journal of Preventive Medicine.
Janet H. Fitzpatrick, M.D., from the Drexel University College of Medicine in Philadelphia, and colleagues examined the associations between extreme temperature conditions and primary care utilization. Analysis included 1.05 million appointments among 91,580 adult patients seen at 13 outpatient clinics (2009 through 2019).
The researchers found that rates of missed appointments increased by 0.72 percent for every 1 degree decrease in daily maximum temperatures below 39 degrees Fahrenheit, and increased by 0.64 percent for every 1 degree increase above 89 degrees Fahrenheit. Associations with an increased rate of missed appointments were stronger for Individuals ≥65 years and those with chronic conditions.
"Primary care physicians should identify vulnerable patients and implement alternative methods of providing care during temperature extremes to decrease the negative impact and reduce the risk of missed appointments," the authors write. "Efforts should be made to support and promote telemedicine as a permanent option to supplement in-person visits. Finally, the knowledge generated can be integrated into medical education so that future physicians are given skills to provide the climate change-related health care needs for their communities."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-26 05:15
Read more
- Certain Women May Need Mammograms Before Age 40 -- An Expert Explains Why
- Ketamine ODs Like the One That Killed Matthew Perry Are Rare But Increasing
- Avadel Pharmaceuticals Announces FDA Approval of Lumryz (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy
- Money, Education Helps Determine Your Odds for Dementia
- Fatty Liver Disease Now Affects 4 in 10 U.S. Adults
- E. Coli Outbreak Linked to McDonald's Quarter Pounders Widens to 75 Cases in 13 States; 22 Hospitalized
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions